Details for Patent: 8,871,759
✉ Email this page to a colleague
Which drugs does patent 8,871,759 protect, and when does it expire?
Patent 8,871,759 protects ZEPATIER and is included in one NDA.
This patent has fifty-three patent family members in forty countries.
Summary for Patent: 8,871,759
| Title: | Inhibitors of hepatitis C virus replication |
| Abstract: | The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5A inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5A activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system. |
| Inventor(s): | Craig A. Coburn, Steven W. Ludmerer, Kun Liu, Hao Wu, Richard Soll, Bin Zhong, Jian Zhu |
| Assignee: | Merck Sharp and Dohme LLC |
| Application Number: | US13/260,684 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 8,871,759
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Msd Sub Merck | ZEPATIER | elbasvir; grazoprevir | TABLET;ORAL | 208261-001 | Jan 28, 2016 | DISCN | Yes | No | 8,871,759 | ⤷ Start Trial | Y | Y | TREATMENT OF PATIENTS INFECTED WITH HEPATITIS C VIRUS | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,871,759
| PCT Information | |||
| PCT Filed | March 25, 2010 | PCT Application Number: | PCT/US2010/028653 |
| PCT Publication Date: | September 30, 2010 | PCT Publication Number: | WO2010/111483 |
International Family Members for US Patent 8,871,759
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2410844 | ⤷ Start Trial | 300858 | Netherlands | ⤷ Start Trial |
| European Patent Office | 2410844 | ⤷ Start Trial | CA 2016 00069 | Denmark | ⤷ Start Trial |
| European Patent Office | 2410844 | ⤷ Start Trial | PA2016048 | Lithuania | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
